18f-fspg
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2014 (NCT02370563)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Also known as
- 18f-fspg
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05322135 | Early Phase 1 (Phase 1) | Sep 14, 2022 | University of Texas at Houston |
| NCT02370563 | Phase 1 | Nov 1, 2014 | Piramal |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Piramal | For profit | 1 | 1 | 1 | 2014 |
| University of Texas at Houston | Academic/Hospital | 1 | 1 | 1 | 2022 |
2 organizations
Page 1 / 1